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Abstract
Objective—To provide an overview of the NIMH Multisite HIV/STD Prevention Trial for
African American Couples conducted in four urban areas: Atlanta, Los Angeles, New York, and
Philadelphia. The rationale, study design methods, proposed data analyses, and study management
are described.
Design—This is a two arm randomized Trial, implementing a modified randomized block
design, to evaluate the efficacy of a couples based intervention designed for HIV serodiscordant
African American couples.
Methods—The study phases consisted of formative work, pilot studies, and a randomized
clinical trial. The sample is 535 HIV serodiscordant heterosexual African American couples.
There are two theoretically derived behavioral interventions with eight group and individual
sessions: the Eban HIV/STD Risk Reduction Intervention (treatment) versus the Eban Health
Promotion Intervention (control). The treatment intervention was couples based and focused on
HIV/STD risk reduction while the control was individual based and focused on health promotion.
The two study conditions were structurally similar in length and types of activities. At baseline,
participants completed an Audio Computer-assisted Self Interview (ACASI) interview as well as
interviewer-administered questionnaire, and provided biological specimens to assess for STDs.
Similar follow-up assessments were conducted immediately after the intervention, at 6 months,
and at 12 months.
Results—The Trial results will be analyzed across the four sites by randomization assignment.
Generalized estimating equations (GEE) and mixed effects modeling (MEM) are planned to test:
(1) the effects of the intervention on STD incidence and condom use as well as on mediator
variables of these outcomes, and (2) whether the effects of the intervention differ depending on
key moderator variables (e.g., gender of the HIV-seropositive partners, length of relationship,
psychological distress, sexual abuse history, and substance abuse history).
Conclusions—The lessons learned from the design and conduct of this clinical trial provide
guidelines for future couples based clinical trials in HIV/STD risk reduction and can be
generalized to other couples based behavioral interventions.
Keywords
HIV; AIDS; STDs; behavioral intervention; HIV serodiscordant couples; clinical trial
Correspondance: NIHM Multisite HIV/STD Prevention Trial for African American Couples, Center for Mental Health Research on
AIDS, Division of AIDS and Health and Behavior Research, National Institutes of Mental Health, National Institutes of Health, 6001
Executive Boulevard, Room 6219B, Bethesda, MD 20892 (wpeguegn@mail.nih.gov).
NIH Public Access
Author Manuscript
J Acquir Immune Defic Syndr. Author manuscript; available in PMC 2010 July 27.
Published in final edited form as:















The National Institute of Mental Health (NIMH) Multisite HIV/STD Prevention Trial for
African American Couples is a randomized trial of a couples based HIV prevention
intervention conducted in four US urban areas: Atlanta, Los Angeles, New York, and
Philadelphia. If successful, the Trial will provide evidence for an intervention urgently
needed to reduce risk behaviors in HIV serodiscordant African American couples. There are
few evidence-based interventions services addressed to their specific HIV/STD risk
reduction needs.
Background and Significance
The impact of HIV/AIDS in the African American community continues to be a health
crisis. Although African Americans constitute approximately 12% of the US population,
they represent 42.4% of people living with AIDS in the US.1 During 2000-2005, African
Americans represented more than half (51%) of the 184,991 reported new cases of HIV in
the 33 states with confidential name-based reporting.2 Rates of HIV/AIDS among African
American men were seven times higher than those among non-Hispanic white men and three
times higher than those among Hispanic men in the years 2000-2003.1 During the same
period, the HIV/AIDS rate for African American women was 19 times the rate for non-
Hispanic white women and five times the rate for Hispanic women.2
Of special concern is the fact that African Americans experienced a shorter interval between
testing HIV positive and being diagnosed with AIDS due to a delay in seeking treatment
associated with poverty and stigma.3 According to the Centers for Disease Control and
Prevention, in 2001, HIV/AIDS was among the three leading causes of death for African
American men aged 25-54 years, among the four leading causes of death for African
American women aged 20-54 years, and the leading cause of death among African
American women 25-34 years of age.4
In the four cities selected for this Trial, the HIV/AIDS prevalence per 100,000 is
disproportionately higher for African Americans (27.1 in Atlanta; 25.9 in Los Angeles; 59.2
in New York City; and 24.9 in Philadelphia).5 The cumulative number of HIV/AIDS cases
in the four cities represents 25% of US cases.5 The prevalence of Chlamydia, the most
common of reported STDs per 100,000, was varied (726.8 in Atlanta; 407.1 in Los Angeles;
437.5 in New York City; and 1,219 in Philadelphia.5 The large proportion of HIV/STDs
cases and geographic diversity represented by the four cities enhances the generalizability of
the proposed study data.5
This Trial is designed for couples because heterosexual contact is the leading route of HIV
transmission among African American women and the second leading transmission mode
among African American men.2 Wyatt and her colleagues reported that almost three of four
HIV positive African American women were infected by their husbands or steady partners.6
Studies have noted low rates of condom use among African Americans,7 African American
women with steady male partners,8,9,10,11 HIV positive African American women,6 and the
HIV negative partners of HIV positive African American women.11 Evidence suggests that
STDs facilitate the spread of HIV.12 A person with an STD is 2-5 times more likely to be
HIV positive than a person without an STD.13
A recent review of condom efficacy studies led by the National Institutes of Health found
that consistent condom use reduces the probability of HIV transmission per sex act by as
much as 95%. Considerable evidence suggests that behavioral interventions can reduce HIV
sexual risk behavior in various populations.14 A meta-analysis of 14 behavioral HIV/STD
prevention interventions among heterosexual adults found statistically significant increases
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in condom use and reductions in incidence of biologically confirmed STDs.15 Interventions
with small groups showed more favorable effects than those with individuals.
While no couples based interventions were included in the meta-analysis, studies with
couples have provided compelling descriptive evidence of the utility of interventions for
dyads. In a study examining couples, Allen and colleagues offered a confidential HIV
testing and condom program for 1,458 childbearing women in Rwanda.16 While not
originally designed as a couples study, 26 per cent of the male partners volunteered to view
the educational videotape and receive an HIV test. Couples in whom both partners were
tested were twice as likely to use condoms. The man’s participation was also associated with
significant reductions in HIV and gonorrhea rates among the women. Of concern was the
finding that seropositive women with untested partners comprised the group least likely to
use condoms, which accounts for the rate of HIV seroconversion in this group being more
than twice that for women whose partners were tested and received counseling. The
strongest predictors of condom use were a seropositive test result in the woman and HIV
testing and counseling of the male partner. At the 2-year follow-up, HIV negative women
whose partners had participated were 50% less likely to become seropositive than were
those whose partners had not participated. Allen continued to corroborate these results and
this program is now being supported by the Global Health Program at the Centers for
Disease Control and Prevention.17
In one of the first studies to evaluate couples based voluntary counseling and testing (VCT)
in the US, Padian corroborated these results in a longitudinal intervention with mixed
serostatus couples.18 The intervention focused on building skills for correctly using
condoms and providing social support, and included role plays for problem solving how to
implement safer sex behavior strategies. Although the study lacked a control group, the data
suggest that the intervention had a positive impact. The proportion of couples reporting
consistent condom use increased from 49 per cent at baseline to 88 per cent at follow-up.
Among those couples at the 16-month follow-up no seronegative partner had become
positive.
The European Study Group on Heterosexual Transmission of HIV documented similar
patterns, suggesting that condom use was associated with fewer seroconversions in 304
serodiscordant couples.19 The couples were counseled and tested for HIV every six months
over 20 months. Nearly half of the couples (48.4%) used condoms consistently, and
experienced no seroconversions. Among those who did not use condoms consistently, 9.9
per cent seroconverted (4.8/100 person years).
Further evidence of the utility of couples interventions comes from a study in Haiti with 476
patients with HIV and their non-infected regular sex partners, who were evaluated at 3 and 6
months for HIV infection, sexually transmitted diseases, and sexual practices.20 Counseling
and free condoms were provided. Only one seroconversion occurred among the 42 sexually
active couples (23.7% of the 177 sexually active couples) who reported always using
condoms. In contrast, the incidence in sexually active couples who infrequently used or did
not use condoms was 6.8 per 100 person years (CI, 6.49 to 7.14 per 100 person years).21
Transmission of HIV was associated with genital ulcer diseases, syphilis, and vaginal or
penile discharge in the HIV negative partner and with syphilis in the HIV infected partner.
The first multi-country randomized controlled trial (RCT) to test the efficacy of VCT with
couples was conducted in Nairobi, Kenya, Dar es Salaam, Tanzania, and Port of Spain,
Trinidad.22 Although it was not specifically designed for couples, the trial enrolled 586
couples, and randomly assigned them to receive either a couples based VCT or a basic
health information intervention. The couples assigned to VCT reduced unprotected
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intercourse with their enrollment partners significantly more than couples assigned to the
health information group. The proportion of individuals reporting unprotected intercourse
with non-primary partners declined significantly more for those receiving VCT compared to
those receiving health information (men, 35% reduction with VCT vs.13% reduction with
health information; women, 39% reduction with VCT vs. 17% reduction with health
information) and these results were maintained at the second follow-up. Individual HIV
infected men were more likely than uninfected men to reduce unprotected intercourse with
primary and non-primary partners, whereas HIV infected women were more likely than
infected women to reduce unprotected intercourse with primary partners.
El Bassel and colleagues conducted one of the first RCTs to test the efficacy of a
relationship based HIV/STD prevention intervention with low-income urban couples in the
US.23,24,25 For this study, 217 low-income urban couples at elevated risk of HIV/STDs were
randomized to one of three conditions: (1) a 6-session relationship based HIV/STD
prevention intervention provided to couples; (2) the same 6 sessions provided to the women
alone; or (3) a 1-session HIV/STD information session provided to the women alone, which
served as the control condition. The 6-session interventions for couples or women alone
were efficacious in reducing unprotected sex at both the 3-and 12-month follow-up
assessments. This study provides additional evidence of the sustained efficacy of a
relationship based intervention for increasing condom use among low-income urban
couples.
While conducted in different settings with African and West Indian samples whose history
of health care access utilization differs from African American couples in the US, the
findings highlight the important of involving couples in HIV prevention efforts. In addition,
all of these studies have one or more of the following methodological drawbacks: not being
designed specifically for couples; relatively small samples sizes; and lacking a randomized
control design, biological confirmed outcomes, or an attention control group. However,
accumulating research has suggested that couples based HIV prevention interventions may
be more efficacious in promoting condom use among HIV serodiscordant couples than
traditional HIV prevention interventions aimed at individuals or groups.16,26,27,28,29,30,31,32
Couples based approaches have been found to be associated with increasing commitment in
a relationship to protecting each other from HIV/STDs, reducing gender power imbalances
that impact condom use, and increasing sexual communication and negotiation skills.
23,33,34,35,36,37,38,39,40,41 The collective results from these studies support the development
of a couples based intervention for African American HIV serodiscordant heterosexual
couples.
The primary objective of this Trial was to develop a culturally congruent, couples based
intervention and test its efficacy in African American serodiscordant couples in four US
cities. The couples were randomized to one of two interventions: an eight session couple
focused Eban HIV/STD Risk Reduction Intervention (treatment) or an eight session
individual focused Eban Health Promotion Intervention (control), addressing health issues
unrelated to sexual behavior. Both interventions involved couple and group sessions led by
trained male and female co facilitators. The treatment intervention focused on couple goals
on how to reduce HIV related risk behaviors and teach condom use and communication
skills. In contrast, the control intervention focused on individual goals related to health
promotion and providing factual information about health screening and teaching skills in
exercise, diet management, and medication adherence.
There are four urban performance sites: Atlanta (Emory University), Los Angeles
(University of California, Los Angeles), New York (Columbia University), and Philadelphia
(University of Pennsylvania), and one data coordinating center (DCC) (University of
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Pennsylvania). Because this Trial is funded through a Cooperative Agreement, NIMH has a
major role in the conduct of the study. Representatives from the sites, DCC, and NIMH
formed a Scientific Steering Committee that developed a common protocol and procedures
for the conduct of the Trial including the interventions; assessment questionnaire; biological
specimen collection, storage, and analysis; study procedures and materials. The Steering
Committee was also responsible for the conduct of all aspects of the Trial. A Data Safety
and Monitoring Board (DSMB), appointed by NIMH, reviewed and approved the Protocol.
The Trial organization appears in Figure 1.
Formative Research
To inform the design of the interventions and study procedures, one four session focus group
was held in Los Angeles, two focus groups were conducted in New York, and two additional
groups were held in Philadelphia. The focus groups were used to inform and refine the
content of the intervention sessions, and barriers to participation in the intervention, such as
transportation and child care. The themes addressed in the focus groups were: (1) stigma and
distress associated with HIV; (2) barriers to condom use; (3) insufficient support from
family and HIV community services; and (4) the lack of skill based interventions that
emphasize valuing self and relationship protection. (See “Formative Study to Develop the
NIMH Multisite HIV/STD Prevention Trial for African American Couples” in this issue.)
The paper and pencil version of the baseline assessment instrument was pilot tested in
Atlanta and Philadelphia. Based on these data, an Audio Computer Assisted Self Interview
(ACASI) version of the questionnaire was developed. All four sites pilot tested the ACASI
version with a new sample of participants and revisions were made. All four sites then
conducted a full pilot study with African American HIV serodiscordant couples using all the
materials developed for the Trial. Six-month follow-up assessments were conducted in
Atlanta and Philadelphia and twelve-month follow-up was conducted in Philadelphia. The
participants were debriefed, and their comments regarding how the study might be improved
were solicited and incorporated into the final questionnaire.
Centralized training programs were conducted for all four performance sites, including: (1)
three-day training for recruiters; (2) three-day training for data collectors; and (3) two-day
training for clinical research coordinators. The facilitators for the two interventions each
received two-part training. The first was onsite where the facilitators watched videos, read
and discussed background materials, and practiced role-playing and implementation of each
session. Then, four days of centralized training was conducted at NIMH for each
intervention separately. All staff was certified after the training by senior staff who
participated in all training.
Randomized Controlled Trial
Research Questions
The primary aims of the Trial were to test the hypothesis that across all four study sites
couples who received the Eban HIV/STD Risk Reduction Intervention (n = 260) relative to
the control couples (n= 275) would have (1) a greater increase in the self reported rate of
condom protected sexual intercourse at immediate post intervention and at 6-and 12-month
follow-up, and (2) a lower incidence of biologically confirmed STDs (Chlamydia,
gonorrhea, and trichomoniasis) at immediate post-intervention and at 6-and 12-month
follow-up.
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The secondary aims of the Trial were (1) to test whether key variables moderate the effects
of the treatment intervention, and (2) to test whether the theoretical mediator variables
changed.
The Trial also tested the hypothesis that across all four urban sites couples who receive the
Eban Health Promotion Intervention relative to the couples in the treatment condition would
increase their health promotion and screening activities.
Research Participants
Participants were 535 English-speaking, African American, HIV serodiscordant,
heterosexual couples recruited in each of the four urban sites (Atlanta = 117 couples, Los
Angeles = 100 couples, New York = 221 couples, and Philadelphia = 97 couples). Three
hundred twenty-three couples had HIV positive female partners and 212 couples had HIV
positive male partners. There were specific inclusion and exclusion criteria associated with
the intervention’s target population.
Eligibility
Couples were eligible to participate if: (1) each partner was at least 18 years of age; (2) each
partner agreed that the relationship had lasted at least 6 months; (3) each partner intended to
stay in the relationship for at least 12 months (i.e., stated independently that he or she was
confident or very confident that they would remain together); (4) at least one partner
reported having unprotected intercourse at least once in the previous 90 days; (5) each
partner had no plans to relocate beyond a reasonable distance from the study site; (6) at least
one partner self identified as African American or black; (7) at least one partner agreed that
they were not planning pregnancy within the next 18 months; (8) each partner was aware of
his/her partner’s HIV status; (9) only one partner was HIV positive and had known their
status for at least three months; and (10) each partner was committed to attending all of the
sessions.
Couples were ineligible if: (1) one or both partners did not have an address where they could
receive mail, which would have made tracking and follow-up difficult; (2) one or both
manifested significant psychiatric, physical or neurological impairment that would limit
their effective participation as confirmed on an MMSE and/or Quick Test; (3) there was a
history of severe physical or sexual abuse in the past year in the current relationship (i.e.,
significant enough to require medical, psychological and/or legal intervention); (4) one or
both partners were unwilling or unable to commit to participating in the study through to
completion; (5) both partners had not previously participated in an HIV sexual risk reduction
intervention for couples in the past 12 months; (6) one or both were not fluent in English as
determined by the Informed Consent process; or (7) both partners were planning to get
pregnant in the next 18 months.
Recruitment and Retention
Because these couples were not receiving services in the traditional recruitment sites and are
a hidden population, it was impossible to determine in advance the best sites or recruitment
methods. To achieve the recruitment targets and to ensure that the results would be
generalizable to multiple settings, research subjects were recruited from HIV care clinics;
HIV testing and counseling centers; primary care clinics; AIDS service organizations;
substance abuse treatment programs; churches with HIV/AIDS ministries; HIV/AIDS
provider networks, coalitions, and advocacy organizations; HIV/AIDS hotline services; and
community based organizations.42,43 The members of the Community Advisory Boards
(CABs) identified specific sites and provided credibility for the recruitment efforts. (See
“The Role of Community Advisory Boards (CABs) in Project Eban” in this issue.)
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Traditional strategies included: presentations and face-to-face recruitment in HIV clinics,
health centers, and CBOs; snowball sampling by eliciting referrals from former participants
who had completed the 12-month follow-up; targeted street outreach; a Project Website; and
brochures and handouts distributed at potential sites with toll free numbers.2
Sources of potential participants were tracked across the sites and appear in Table 1.
To increase the number of eligible couples, some sites expanded the recruitment strategies to
nontraditional recruitment approaches such as media. At Emory University and UCLA, the
investigators implemented a media recruitment campaign. Table 2 illustrates the increase in
the percentage of couples under 30 recruited using these methods. Specifically, the two sites
that implemented media campaigns, observed a 160% increase (Atlanta/Emory) and 260%
increase (UCLA/Los Angeles) in the percentage of new study participants recruited who
were < 30 years of age. It was important to recruit younger couples in order to increase the
baseline prevalence of STDs in the sample. The sources of participants who were
randomized appears in Table 3.
Design and Methods
There was a detailed Project Eban Participant Visit Schedule that was followed across the
sites, which appears in Figure 2. There were three phases of the Trial: (1) the pre-
intervention phase; (2) intervention phase; and (3) follow-up phase.
Pre-Intervention-Phase
This phase was a maximum of 90 days. At Visit 1, couples were initially screened, their
interest in participating was assessed, and they received Informed Consent. At Visit 2, each
participant was screened to determine couple eligibility. No additional data were collected
for ineligible couples. Refusal data were collected for eligible couples that declined to
participate. Eligible couples that wished to continue completed a Short Locator Form (for
each individual), which was used to maintain contact with each participant throughout the
trial. Participants were also asked to provide picture identification. The Data Collector gave
each participant the ACASI instructions and practice questions. After completing the
ACASI, participants received face-to-face interviews in private rooms. Pretest HIV/STD
counseling preceded collection of specimens, which were shipped to a centralized testing
facility at Emory University. Specimens for Neisseria gonorrhoeae (GC) and Chlamydia
trachomatis (CT) were assessed using the Becton Dickinson ProbeTec ET Amplified DNA
Assay, (Becton, Dickinson and Co., Sparks, MD) and Trichomonas vaginalis (TV) was
assessed using Taq-Man PCR. At the end participants were then scheduled for
randomization and the initial intervention session within 10-14 days, and reimbursed.
After completing baseline measures at Visit 2, participants were asked to provide an oral
specimen, using the OraSure test procedures, as defined by the Epitope system, to confirm
their HIV status. Testing with OraSure requires no blood or needles. The accuracy of the
OraSure HIV-1 oral specimen test ranged from 97.7% in high-risk populations to 99.6% in
low risk populations. If an OraSure specimen tests repeatedly reactive with the Oral Fluid
Vironostika HIV Microelisa System, that specimen undergoes further testing for HIV-1
antibodies with the more specific OraSure HIV-1 Western Blot Kit. All participants received
standard pre- and posttest counseling from the site CRC, who was trained and certified to
conduct such counseling. Participants who were identified as HIV positive were informed in
private and referred to clinical sites for further diagnostic evaluation and care.
Detected STDs were treated according to CDC guidelines. After notification, participants
were treated immediately or scheduled to return to a designated clinical site for treatment by
a project clinician. For both ethical and methodological reasons, it was imperative that
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treatment was completed promptly and that confirmation of treatment was obtained.
Participants were treated with directly observable, state-of-the-art, single dose, oral therapy
to minimize potential non-adherence to multi-dose medication regimens.
Intervention Phase
This phase occurred within 21 days of Visit 2. At Visit 3 couples were reconfirmed for
eligibility, randomized to either the treatment or control intervention, and participated in the
first intervention session. Also, posttest counseling and test results were provided and, if
required, the couples were treated for any positive results. Treatment procedures followed
local or CDC guidelines as appropriate. Participants randomized to both conditions received
HIV/STD education when the biospecimens were collected and treatment was rendered.
During this period Intervention sessions 2 to 8 were delivered, allowing only 7 to 13 days
between sessions.
Follow-up Phase
This phase began within 10 days after the intervention ended. At Visits 11-13 the data
collection activities in Visit 2 were repeated at immediate post-intervention, 6 months, and
12 months, respectively.
Randomization
In contrast to traditional randomized trials, which randomize individuals to intervention
conditions, this couples based, randomized trial assigned intact couples to either the
treatment or control condition in groups of three to five couples. The gender of the HIV
positive partner was used as a blocking factor to ensure that the distribution of HIV positive
males and females was equal across interventions. (See paper on the randomization
procedures.44)
Interventions
Previous studies have established that eight sessions ensure that problems emerge and the
skills required for behavior change can be acquired. Male and female co-facilitator pairs
delivered a standardized intervention based on the criteria in the manual that was reinforced
by training and weekly supervision. supervision. (See “Supervision Model Used to Ensure
Fidelity of Intervention Implementation” in this issue.)
Eban HIV/STD Prevention Intervention (Treatment)
The Eban HIV/STD Risk Reduction Intervention was based on three integrated theoretical
foundations (i.e., social cognitive theory, an ecological framework, and an Afro centric
paradigm), which were incorporated into the structure, format and content of the curriculum.
(See Figure 3.) The couples focused intervention, which consisted of eight weekly two-hour
sessions, was structured and addressed on personal, interpersonal, community, and societal
levels (ecological model). The facilitators modeled self-protection, working together, and
communication, and supported all aspects of healthy interactions. The intervention relied on
dyadic and group processes and allowed facilitators to use strategies that addressed the
broad array of interpersonal, social, and cultural factors influencing risk behavior among
HIV affected couples.
The intervention was tailored to the realities of urban African American couples and focused
on the enhancement of positive evaluations of self-worth, self-esteem, ethnic pride, and risk
avoidance. The content of this culturally congruent curriculum combined skills building
exercises guided by Nguza Saba principles that promote valuing health and working
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together to preserve families and communities. The intervention incorporated Eban, a
traditional African concept meaning “fence,” a symbol of safety, security, and love within
one’s family and relationship space. Group sessions promoted a “village concept” of
collective support to a community surrounded and protected by Eban. Group cohesion was
encouraged through certain group activities, including opening and closing rituals, the
“talking circle,” and the setting of group rules for safety and respect. Elements of the
intervention that foster application of the Nguza Saba for practicing safer sex were followed
by exercises that promote sexual risk reduction skills. (See “Eban HIV/STD Prevention
Intervention: Conceptual Basis and Procedures” in this issue.)
Eban Health Promotion Intervention (Control)
The Eban Health Promotion Intervention was the control condition that was also an active
intervention with health related endpoints. In contrast to the treatment condition, this
intervention was guided by a social cognitive approach to developing health promotion
skills without providing cultural context or gender tailoring. (See Figure 4.) It focused on
setting goals for individuals and did not encourage partners to work together in choosing
healthier behaviors.
Although the intervention did not focus on HIV/STD risk reduction, because of the ethical
obligations to serodiscordant couples, HIV/STD testing and counseling were provided
during all assessment visits. Also, in the intervention sessions, participants were presented
information and skills to increase their adherence to medication regimens, including those
for HIV. The presentation focused on behaviors related to risk for certain cancers,
hypertension, and heart disease, which are the leading causes of morbidity and mortality
among African Americans. Participants were taught that changing personal behaviors can
prevent these diseases. The behaviors included increasing physical activity and healthy
dietary practices, cessation of cigarette smoking and abusing alcohol and drugs, and
practicing early detection and screening behaviors (e.g., breast and testicular self-
examinations and Pap smears). Because all couples received an active intervention and
participated in VCT, this intervention addressed the ethical issues and minimized differential
attrition between conditions. (See “Eban Health Promotion Intervention: Conceptual Basis
and Procedures” in this issue.)
Assessment of Outcomes
The assessment activities were designed to measure the constructs central to the theoretical
frameworks on which the interventions were designed. (See Figures 3 and 4 for these
constructs.) The behavioral questionnaire in ACASI included 296 questions for baseline,
217 for IPT, and 299 for the 6 month and 12 month and 50 questions in the face-to-face
interview. There were six questions focused on the behavior outcome.45 (See “Developing
an Audio Computer-Assisted-Self-Interview (ACASI) for a Multisite Trial” in this issue.)
Data on childhood sexual abuse, physical abuse, relationship satisfaction, and social
desirability were collected using a face-to-face survey. If a participant displayed significant
distress, the Data Collector halted the assessment and the participant was provided brief
counseling and referred for mental health services.
There were intervention specific primary endpoints of interests including two primary
endpoints (behavioral and biological) for the treatment intervention. The primary behavioral
endpoint for the treatment intervention was reduction in HIV/STD risk behavior that was
assessed independently for each couple member using six self report questions about sexual
practices with study partners) The primary biological endpoint was reduction in incident
STD cases (Chlamydia, gonorrhea, and trichomoniasis) during any of the follow up phases
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(IPT, 6 and 12 months). The primary endpoint for the control intervention was an increase in
health promoting behaviors (screening for cancer, diet, exercise).
The assessment sessions involved approximately two hours each at baseline, 6-and 12-
month follow-up. To maintain the integrity of the intervention, the Data Collector was
blinded to treatment condition and interacted with couples only on assessment issues. A
Data Collector was available to assist with ACASI.
(See “Challenges of Selecting Outcome Measures for the NIMH Multisite HIV/STD
Prevention Trial for African American Couples” in this issue.)
Data Analysis Plans
The Trial will not complete final data collection until August 2008 and therefore the plans
for analysis are presented below.
The primary objective of this study was to test the efficacy of a couples based HIV sexual
risk reduction intervention versus a health promotion control group in increasing condom
use and reducing STD incidence in a sample of African American HIV serodiscordant
couples. More than 500 couples were randomized to each of the two interventions. Data
were collected at baseline, IPT, 6-and 12-months post-intervention. The aims were
concerned with within couple specific variation and between treatment differences. Parallel
intent-to-treat and completer analyses will be performed for all study aims. Attrition rates
will be examined for comparability between the two treatment conditions. If the attrition
rates differ, variables related to attrition might constitute confounding factors that limit
internal validity; accordingly, such variables will be used as covariates. General statistical
design issues for the proposed study, including topics that cut across aims, are highlighted.
Analysis of Baseline Data—Baseline data for eligible enrolled participants will be
compared to data for participants not enrolled, in order to temper the generalizability of the
trial results. Additionally, baseline data were compared across intervention conditions, to
ensure that the couples randomized to each intervention were comparable. These summaries
across the Trial and by sites were prepared by the DCC for review by the Steering
Committee on a quarterly basis and at least every six months by the DSMB, which permitted
monitoring the progress and data quality of the Trial.
Analysis of Primary Endpoints at Follow-up—The primary aims focus on testing for
significant differences in sexual risk behaviors and STD incidence between the two
conditions. Outcome measures for primary analysis are couple specific incident rates of
condom protected sexual contact and STD incidence over the 12-month follow-up period. In
addition, the secondary aims are to: (1) identify variables that moderate the intervention
induced changes in the primary outcome variables and (2) determine variables that mediate
the effects of the intervention. Additionally, the effects of moderators and mediators in
examining other secondary behavioral outcomes (e.g., number of condom protected oral sex
acts, etc.) will be examined.46 Major statistical challenges in testing these hypotheses arise
in the proper handling of repeated clustered outcomes. Each variable of interest was
completed by each partner of each couple, thus creating correlated outcomes. Each couple
was nested within a cohort of 3 to 5 couples, which was further nested within one of the four
study sites. Multiple assessments of each variable over the study period produce repeated
outcomes for each couple. Thus, the analytic strategy accommodated the unique multilevel
nested structures of the data.
The primary challenge in the analysis of such data will be to make appropriate adjustments
for the differential treatment means between clusters, and the correlations among the
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observations within a cluster (cluster effects). Each nested level of the study design will
form a cluster. Most statistical models assume stochastic independence among observations,
and thus are inappropriate for clustered data. The two most common approaches for
handling clustered data are mixed effects modeling (MEM) and generalized estimating
equations (GEE) modeling. The MEM approach employs normal variates (random effects)
to account for the within cluster correlations, and uses standard likelihood methods for
statistical inferences, whereas GEE modeling avoids explicit modeling of the within cluster
correlations by basing statistical inferences of model parameters on marginalized likelihood
or generalized estimating equations. Although MEM is inappropriate for non-normal data
because it uses normal variates for both cluster effects and model errors, it is appropriate if
the data are approximately normal. The normality assumption was examined in this study
using various descriptive statistics such as histogram and quartile plots based on the
standardized residuals. GEE requires a relatively large sample size (e.g., large numbers of
small clusters), which this study satisfied. The implementation of both approaches for this
study is relatively straightforward. For both approaches, between cluster variations such as
treatment differences are modeled by fixed effects. Modeling of the within cluster
correlations is not required for GEE; for MEM, such correlations are modeled by random
effects. Although site differences may be treated as either fixed or random effects, such
differences will be modeled using fixed effects, because such a strategy will enable
examination of possible site-by-treatment interactions. Ultimately, the choice of MEM and/
or GEE will be based on each approaches strengths and limitations, based on the underlying
assumptions of each modeling approach.
An intent-to-treat analysis, for which all available data on all randomized participants are
included, will be used for the primary control of the two intervention conditions. Every
attempt will be made to keep missing data to a minimum, and participants who fail to attend
intervention sessions were strongly encouraged to complete follow-up assessments.
Analyses to examine whether screened eligible non-participants and participants differ on
screened variables will be performed. Attrition analyses will be performed on whether
participants and dropouts differ on key variables (informative censoring), and whether
variables on which they differ interact with the intervention to affect outcome measures. A
few randomly missing observations have only a slight impact upon study power and do not
introduce biases. Larger numbers of nonrandom missing data (e.g., if distressed participants
are not compliant) can bias study findings. Various methods were used to determine the
severity of missing data on the results of the analyses. Sensitivity analyses for all hypotheses
under various missing data correction methods were examined. If a finding was not
dependent on the missing data mechanism, then significant findings should be consistent
across all imputation methods. The number and proportion of missing data points estimated
by these methods will be reported. Analyses were conducted with and without interpolated
data and any differences in results were reported.
There are two major outcomes for the primary hypotheses, one behavioral and the other
biological. Since these two outcomes may be correlated, it is difficult to control for Type I
error arising from using them in testing the primary hypotheses. The common Bonferroni
procedure for adjusting Type I error within such a multiple control setting is likely to be
unnecessarily conservative. Thus, the general principle is to use multiple control procedures,
mostly for the secondary analyses, since they are based on weak a priori hypotheses. By
using multiple comparison procedures selectively, the study will guard against Type I errors
and avoid being too conservative, thereby protecting against missing important statistical
findings.
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Because this Trial recruited HIV serodiscordant African American couples, there was a
strong imperative to design a trial adhering to the highest ethical standards for research
subjects. (See “Ethical Issues in Designing and Conducting a Trial for Serodiscordant
Couples” in this issue.)
Informed Consent
At Visit 1 the study was preliminarily discussed and informed consent was provided. At
baseline (Visit 2), the interviewer explained the aims, requirements, risks and benefits of the
study. The interviewer assisted participants in understanding the informed consent form,
which had been reviewed by both the Institution’s IRB and the NIMH appointed Data Safety
Monitoring Board (DSMB). Participants were asked to sign and date the form and were
given a copy. Signed informed consent forms were kept in locked files in a locked office
with restricted access.
After consent, the interviewer reconfirmed eligibility and completed a Short Locator Form.
Each subject was then escorted to a gender specific testing room and given instructions on
how to complete the ACASI. When it was completed, each person was escorted to a private
room for a face-to-face interview. Next, each subject received protesting counseling and
provided urine specimens. Women also provided a self-administered vaginal swab.
Participants were then reimbursed and scheduled within a 21-day window for
randomization.
Reimbursement
Each subject received a total of $395 for participating in all eight intervention sessions and
four data collection sessions over 14 months. Participants received $5 for initial screening
and $5 for confirmatory screening. Also, participants received $25 for post-intervention
assessment, $50 for 6-and 12-month follow-up assessments, and $10 for each urine or
vaginal specimen provided at any of the assessment points.
Data Safety and Monitoring Plan
Ongoing monitoring ensured that there were no undue risks to participants, that participants
in one arm were not experiencing more adverse events than the other, and that the data were
being collected in a valid and reliable way. All staff and investigators had been trained to
identify and report potential adverse events and to implement corrective actions. Three
entities provided ongoing monitoring of the trial: (1) Steering Committee and the DCC; (2)
the local IRB and in country IRB; and (3) the NIMH and the DSMB. Because there was
limited experience with adverse events when working with African American serodiscordant
couples, the Steering Committee decided to cast a broad net and collect information on all
unusual events and classify them later. All events were reviewed by each site’s respective PI
within 24 hours of the event, reported to the DCC and then reviewed by the SC on its next
conference call. The Steering Committee determined whether the event was related to the
study in any way, whether it met criteria for an adverse event and what corrective action
should be taken. Adverse events must be reported to the IRB. The IRB reviewed and
approved all local informed consent forms and procedures. Each time a change was made in
the protocol, the IRB was asked to approve it. To date, the Steering Committee has not
identified any adverse events.
Quality Control/Quality Assurance Procedures
In this Trial, quality control (QC) procedures are the methods used to ensure that data were
collected in a standardized way and interventions were implemented in a similar fashion
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across sites with fidelity to the Protocol. This included development of a detailed Protocol,
using standard criteria for hiring staff, consistent staff training and supervision, and
development of manualized interventions.47 Quality assurance (QA) procedures addressed
adherence to the protocol and study procedures, assessment, and interventions, as well as
whether the quality control procedures were effective. They included onsite quality
assurance led by PIs or designees and central monitoring (coordinated by the DCC and
designated sites). There are three major components of a QC/QA model adopted in this
Trial: (1) personnel, (2) manuals for the multisite study, and (3) ongoing monitoring of
adherence to study procedures. (See Table 3 for the model.)
Study Personnel
For each role in the Trial there was a detailed job description, educational requirements, and
practical experience. All study personnel were trained both at the site and centrally. Ongoing
supervision by a well trained research staff at each site and ongoing feedback across sites on
conference calls were found to be effective ways to maintain a high level of adherence to the
Protocol.
Manuals for the Multisite Study
A complete Protocol was developed that detailed how all aspects of the Trial should be
implemented. There were also complete training manuals for implementing the Assessment,
Biospecimen Collection, and the Interventions.
Ongoing Monitoring of Adherence to Study Procedures
Site visits were conducted for all aspects of the Trial. The Quality Assurance Monitor for the
interventions, observed sessions, interviewed facilitators, and reviewed files. Ten percent of
the sessions in each cohort were reviewed via audio recordings. The Session Adherence
Scale, developed for this study and using the same quantitative items as the Facilitator
Session Implementation Form, was tailored to the content of each session for each arm. It
was used to assess how adequately the key elements of the session were addressed and the
time spent delivering each element. The Facilitation Skills Scale, also developed for this
study, was a quantitative measure with a different version for each arm. It assessed
facilitators’ adherence to the intended delivery style. To ensure sufficient reliability of these
two measures, two raters reviewed 50% of the selected audio recordings for the first cohort
and interpreter reliability was checked.
The data collectors were trained by the DCC that provided feedback to them after review of
the ACASI and face-to-face interview data.
A team at Emory University provided feedback and generates detailed reports on adherence
to biospecimen procedures. Site visits are conducted annually to observe CRCs conducting
biospecimen procedures. A standard form outlining feedback was provided to the PI, DCC,
and the SC for review. Significant deviation from the biospecimen protocol was an
indication that the site needed retraining.
Summary
This Trial is an innovative example of how social, behavioral, and biological scientists
collaborate to tackle the unrelenting HIV epidemic among African American HIV
serodiscordant couples. The successful completion of this Trial will advance the knowledge
base on couples based HIV prevention intervention research with the following innovative
achievements, as the Trial: (1) addressed previous methodological limitations by using a
rigorous RCT design to test the efficacy of the intervention in increasing self reported
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condom use and decreasing the incidence of biologically confirmed STDs over a 12-month
follow-up period among more than 500 African American HIV serodiscordant couples; (2)
adapted an Afro centric, culturally congruent approach to build self efficacy to protect
oneself, one’s partner, and the African American community from HIV/AIDS and to reduce
stigma and social isolation experienced by African American HIV serodiscordant couples, a
population which remains underserved and at very high risk of HIV/AIDS transmission; (3)
employed a multisite design replicating a common protocol in four geographically diverse
cities, which represent 25% of all HIV/AIDS cases nationally, increasing the generalizability
of the findings; (4) used a novel mixed modality approach in which couples benefit both
from sessions as individual couples and from sessions with groups of couples; (5) adopted
an innovative strategy to ensure that STDs acquired over the follow-up period are incident
infections (many HIV prevention trials use STDs to determine intervention efficacy); and
(6) allowed for progress reports to be made available to CABs and the collaborating
agencies on a regular basis and a summary of the major findings of the study were made
available to the four groups at its completion.
In individual level interventions. the participant may become reinfected if they have unsafe
sex with a partner who is not treated. The Eban protocol, by testing and treating both
partners of a couple, ensured that the HIV and STD cases detected in the couple were
incident cases.
This study has the potential to significantly contribute to the prevention of HIV/STDs in the
African American community and with serodiscordant couples. African American couples
affected by HIV have been ignored by the research community, especially in the context of
designing culturally tailored and theoretically sound risk reduction interventions. Whether
the couples were randomized to the treatment or control condition, they benefited by
learning how to reduce their health risks and to enhance their overall health. If both
interventions demonstrate efficacy, the investigators will collaborate with the CABs and the
agencies from which the Trial recruited to facilitate adoption of these evidence based
prevention programs for these underserved populations in order to stop the dual epidemics
of HIV/STDs and chronic illnesses.
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Schedule of Study Sites
Schedule of Study Visits
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Conceptual Framework for Eban HIV/STD Risk Reduction Intervention
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Conceptual Framework for Eban Health Promotion Intervention
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Increase in Couples Enrolled who are Less than 30 Years of Age Before and After Implementing a Media
Campaign
Site Percent < 30 Years of Age Prior to Mass Media
Recruitment Efforts
Percent < 30 Years of Age After Mass Media
Recruitment Efforts
Percentage Increase
Atlanta 5.9% 9.8% 160%
Los Angeles 7.1% 18.2% 260%






























































































































































































































































































































































































Components of Model of Quality Control/Quality Assurance Plan
Study Personnel ◆ Selection criteria
◆ Job description
◆ Training procedures
◆ Certification for procedures
Manuals for the multisite study ◆ Study procedures
◆ ACASI and interview
◆ Interventions
◆ Biospecimen collection, storage, shipping, analysis
Ongoing monitoring of adherence to study procedures ◆ Onsite and central monitoring
◆ Instruments for monitoring procedures
◆ Specification of corrective feedback procedures for protocol violations
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